ABT-354
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABT-354, covering 2013-12-11 to 2013-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors [Phase 1]